These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19626152)

  • 1. Recent advances in the management of adenocarcinoma of the small intestine.
    Overman MJ
    Gastrointest Cancer Res; 2009 May; 3(3):90-6. PubMed ID: 19626152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment and outcome in small bowel cancer].
    Ogata Y; Yamaguchi K; Sasatomi T; Uchida S; Akagi Y; Shirouzu K
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1454-7. PubMed ID: 20716869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small bowel adenocarcinoma (SBA) three years after colonic adenocarcinoma in an elderly patient: Case report in a National Institute of Health and Aging (INRCA) and review of the literature.
    Coco D; Leanza S; Boccoli G
    Int J Surg Case Rep; 2014; 5(12):939-43. PubMed ID: 25460441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare but real: management of small bowel adenocarcinoma.
    Overman MJ
    Am Soc Clin Oncol Educ Book; 2013; ():189-93. PubMed ID: 23714497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.
    McWilliams RR; Foster NR; Mahoney MR; Smyrk TC; Murray JA; Ames MM; Horvath LE; Schneider DJ; Hobday TJ; Jatoi A; Meyers JP; Goetz MP
    Cancer; 2017 Sep; 123(18):3494-3501. PubMed ID: 28493308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
    Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
    Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
    Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
    Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of small bowel adenocarcinoma.
    Kummar S; Ciesielski TE; Fogarasi MC
    Oncology (Williston Park); 2002 Oct; 16(10):1364-9; discussion 1370, 1372-3. PubMed ID: 12435206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Anatomic Extent of Nodal Metastasis on Adjuvant Chemotherapy Outcomes in Stage III Colon Cancer.
    Woo IT; Park JS; Kang BW; Park SY; Kim HJ; Choi GS; Gwang Kim J
    Dis Colon Rectum; 2020 Oct; 63(10):1455-1465. PubMed ID: 32969889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
    Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA
    J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and prognostic factors for localised small bowel adenocarcinoma.
    Colina A; Hwang H; Wang H; Katz MHG; Sun R; Lee JE; Thomas J; Tzeng CW; Wolff RA; Raghav K; Overman MJ
    ESMO Open; 2020 Nov; 5(6):e000960. PubMed ID: 33188051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
    Kim Y; Squires MH; Poultsides GA; Fields RC; Weber SM; Votanopoulos KI; Kooby DA; Worhunsky DJ; Jin LX; Hawkins WG; Acher AW; Cho CS; Saunders N; Levine EA; Schmidt CR; Maithel SK; Pawlik TM
    Surgery; 2017 Aug; 162(2):285-294. PubMed ID: 28578142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Small bowel adenocarcinoma].
    Zaanan A; Afchain P; Carrere N; Aparicio T
    Gastroenterol Clin Biol; 2010; 34(6-7):371-9. PubMed ID: 20537487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of adenocarcinoma of small intestine surviving for many years].
    Sawazaki S; Saeki H; Tominaga N; Shimada Y; Hayashi S; Takata K; Kato N; Osawa H; Fujisawa J; Matsukawa H; Kawano N; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):393-5. PubMed ID: 23507606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
    Huffman BM; Jin Z; Yadav S; Patel S; Nagorney DM; Truty MJ; McWilliams RR; Halfdanarson TR; Mahipal A
    Clin Colorectal Cancer; 2019 Sep; 18(3):218-225. PubMed ID: 31178274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 19. Intussuscepted Metachronous small bowel tumor after treatment for colorectal adenocarcinoma.
    Curbelo-Peña Y; Saavedra-Perez D; Stickar T; Molinas-Bruguera J; De Cozar-Duch J; Quer-Vall X; Vallverdú-Cartie H
    Int J Surg Case Rep; 2019; 60():94-97. PubMed ID: 31212095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management and outcome in primary adenocarcinoma of the small bowel.
    Agrawal S; McCarron EC; Gibbs JF; Nava HR; Wilding GE; Rajput A
    Ann Surg Oncol; 2007 Aug; 14(8):2263-9. PubMed ID: 17549572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.